Skip to main content
Envío gratis en todos los pedidos
888-559-3802

Acidophilus Probiotic Blend | Multi-Strain Gut Support

Explore our acidophilus Probiotic Blend with 6 research-backed strains plus prebiotics. Learn how it supports gut microbiome health, digestion, and immune function.

Overview

What Is an Acidophilus Probiotic Blend?

An acidophilus Probiotic Blend is a multi-strain probiotic formula built around Lactobacillus acidophilus and complementary bacterial strains that work together to promote digestive health, gut microbiome balance, and immune function. Rather than relying on a single organism, a well-designed blend delivers a diversity of beneficial bacteria—each with distinct mechanisms of action—to support the gastrointestinal tract from the stomach through the large intestine.

Vitabase Probiotic Blend is a complete gastrointestinal support complex that delivers 750 million CFUs at the time of manufacture across six well-researched probiotic strains: Bacillus subtilis (DE111®), Bacillus coagulans, Bifidobacterium bifidum, Lactobacillus rhamnosus, Lactobacillus acidophilus, and Lactobacillus paracasei. Alongside these probiotics, the formula includes two prebiotic fibers—FOS (fructooligosaccharides) and XOS (Xylooligosaccharides)—that serve as food for the beneficial bacteria, helping them thrive and enhancing their effectiveness.

This acidophilus Probiotic Blend is formulated with GMO-free ingredients and uses vegetable capsules for easy digestion. It is also gluten free. Each bottle contains 120 capsules, and the product may be refrigerated to help maximize shelf-life and potency.

How It Works

How a Multi-Strain Probiotic Blend Supports Your Body

The six probiotic strains in this acidophilus Probiotic Blend each contribute through complementary pathways. The spore-forming strains—Bacillus subtilis (DE111®) and Bacillus coagulans—are uniquely resistant to stomach acid and bile, arriving in the intestine with near-complete viability. Research suggests that Bacillus subtilis spores survive gastric transit at a rate of nearly 100%, germinate in the intestine, and consume oxygen to create an anaerobic environment favorable for Lactobacillus and Bifidobacterium. Bacillus coagulans germinates within four to six hours of entering the duodenum, producing lactic acid and bacteriocins that help lower intestinal pH and inhibit pathogenic bacteria.

The Lactobacillus strains—acidophilus, rhamnosus, and paracasei—are among the most extensively studied probiotic species for digestive and immune health. Lactobacillus acidophilus produces lactic acid, bacteriocins, and bile salt hydrolases, and its S-layer proteins promote adhesion to intestinal epithelial cells. Lactobacillus rhamnosus secretes proteins p40 and p75 that support intestinal barrier integrity and promote IgA production. Lactobacillus paracasei produces exopolysaccharides associated with immune modulation and tight junction enhancement.

Bifidobacterium bifidum is a natural colonizer of the human colon and lower small intestine. Studies suggest it enhances the intestinal epithelial tight junction barrier through a Toll-like receptor-2 (TLR-2) mediated pathway, and it plays a key role in early-life gut colonization due to its unique ability to metabolize human milk oligosaccharides.

The prebiotic duo of FOS and XOS completes the formula by selectively feeding Bifidobacterium and Lactobacillus species in the colon. Research suggests that FOS supplementation increases beneficial bacteria and promotes production of short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate—metabolites linked to improved intestinal barrier integrity and reduced inflammatory signaling. XOS achieves comparable bifidogenic effects at lower doses than many other prebiotics, and studies suggest it also supports tight junction protein expression and gut barrier function.

What's inside

Key Ingredients

FOS (fructooligosaccharides) — 150 mg
FOS is a well-established prebiotic fiber classified as GRAS by the FDA. It resists digestion in the upper gastrointestinal tract and is selectively fermented in the colon by beneficial bacteria—particularly Bifidobacterium and Lactobacillus—making it one of the most studied prebiotics for gut microbiome health. A systematic review of 26+ human RCTs confirms its bifidogenic and butyrogenic effects. Research suggests that FOS fermentation produces short-chain fatty acids (SCFAs) including butyrate, which nourish colonocytes, support intestinal epithelial barrier integrity, and modulate immune responses. A 2024 systematic review and meta-analysis of 17 RCTs (713 participants) found that FOS significantly increased bowel movement frequency, improved stool consistency, and reduced effort and pain during defecation. Studies also suggest FOS may enhance intestinal absorption of calcium, magnesium, and iron through colonic pH reduction. FOS supports the digestive system, immune system, and colon health, and its prebiotic activity may indirectly benefit the gut-brain connection through SCFA-mediated serotonin metabolism.
XOS (Xylooligosaccharides) — 50 mg
XOS is a prebiotic oligosaccharide derived from xylan that resists mammalian digestive enzymes and is selectively fermented by Bifidobacterium in the colon. It has obtained GRAS status from the FDA and is recognized as a novel food by EFSA. A key advantage of XOS is its potency at low doses: a double-blind, randomized, placebo-controlled human study demonstrated that XOS achieves bifidogenic effects at just 1.4–2.8 g/day—roughly 5 to 10 times less than the dose of FOS required for comparable results. Studies suggest XOS fermentation produces SCFAs—particularly butyrate—that strengthen the gut barrier by increasing tight junction proteins (ZO-1, occludin, claudin-1) and support colonic immune modulation. A randomized, double-blind controlled trial in patients with functional constipation found XOS supplementation improved symptoms and was associated with targeted enrichment of Bifidobacterium. Research also suggests XOS may support mineral absorption through colonic pH reduction, with animal studies showing improved bone mineral density at higher doses.
DE111 (Bacillus subtilis) — 750 million CFU
Bacillus subtilis DE111® is a spore-forming probiotic bacterium that positively modulates gut microbiota composition. Its endospore form allows it to survive the harsh gastric environment with nearly 100% viability, germinating in the small intestine as metabolically active vegetative cells. Research suggests DE111® inhibits colonization of pathogenic bacteria, supports intestinal epithelial barrier function, and modulates gut immune responses. In a randomized, double-blind, placebo-controlled trial, Bacillus subtilis BS50 (a related strain) at 2 × 10⁹ CFU per day increased the proportion of participants showing improvement in bloating, burping, and flatulence compared to placebo. DE111® has been the subject of a GRAS notification with the FDA and has demonstrated the presence of vegetative cells in the human small intestinal tract, suggesting metabolically active bacteria are present producing key beneficial molecules. It produces antimicrobial compounds including iturin and fengycin that may help support large intestinal health.
Bacillus coagulans — 750 million CFU
Bacillus coagulans (Heyndrickxia coagulans) is a spore-forming, lactic acid–producing probiotic with GRAS status. Its spores withstand high temperatures, acidity, and bile salts, germinating into active vegetative cells in the small intestine within four to six hours. Multiple randomized, double-blind, placebo-controlled trials have evaluated this species for IBS, with consistent improvements reported for abdominal pain, bloating, diarrhea, and stool consistency. In one 90-day RCT, B. coagulans MTCC 5856 at 2 × 10⁹ CFU/day significantly improved bloating (p = 0.0037), diarrhea (p = 0.0026), and abdominal pain (p = 0.0001) versus placebo in IBS-D patients. Studies also suggest it may support immune function: a 12-week RCT demonstrated a 42% net increase in natural killer (NK) cell activity versus placebo. It produces lactic acid, bacteriocins, digestive enzymes, and short-chain fatty acids that collectively support digestive system health and immune balance.
Bifidobacterium bifidum — 750 million CFU
Bifidobacterium bifidum is a naturally occurring resident of the human colon, lower small intestine, and breast milk, and is among the first colonizers of the neonatal gut. Research suggests it causes a marked, sustained enhancement in intestinal epithelial tight junction barrier function through a TLR-2 mediated pathway. In a landmark 4-week RCT of 122 IBS patients, B. bifidum MIMBb75 significantly reduced global IBS symptoms—including pain, distension, and bloating—with responder rates of 57% versus 21% for placebo. A subsequent larger trial (443 patients) confirmed benefit even with heat-inactivated bacteria. Studies suggest B. bifidum supports immune modulation by expanding T-regulatory cell responses and modulating cytokine profiles, including enhanced IL-10 production. It has also demonstrated the ability to inhibit pathogens through organic acid production and immune stimulation, and its specialized capacity to degrade human milk oligosaccharides gives it a competitive advantage for colonization in the gut.
Lactobacillus rhamnosus — 750 million CFU
Lactobacillus rhamnosus (Lacticaseibacillus rhamnosus) is among the most extensively studied probiotic species worldwide. Its SpaCBA pili promote strong adhesion to intestinal epithelial cells and mediate anti-inflammatory effects by inducing IL-10 production. Secreted proteins p40 and p75 support the epithelial barrier, promote IgA production, and stimulate mucin gene expression. A systematic review and meta-analysis of 12 RCTs (1,499 participants) found that the GG strain reduced the risk of antibiotic-associated diarrhea from 22.4% to 12.3%. Research also suggests it may reduce upper respiratory tract infections: a 571-child double-blind RCT found a 17% relative reduction in respiratory infections with complications. Studies have evaluated L. rhamnosus for IBS symptom management, gut barrier reinforcement, and modulation of both innate and adaptive immune responses. The strain GR-1 has specifically been studied for urogenital health, with oral administration resulting in vaginal colonization and restoration of vaginal flora.
Lactobacillus acidophilus — 750 million CFU
Lactobacillus acidophilus is the cornerstone species of this acidophilus Probiotic Blend and one of the most studied probiotic bacteria. Its S-layer protein A (SlpA) facilitates adhesion to intestinal epithelial cells and modulates dendritic cell responses, inducing the anti-inflammatory cytokine IL-10. A dedicated meta-analysis of RCTs (1,171 subjects) found L. acidophilus significantly increased CD4+ T-cells and IgA while reducing IL-6 and TNF-α. Studies suggest it supports lactose digestion through β-galactosidase production: a double-blind crossover study of the DDS-1 strain found significant improvements in diarrhea, abdominal cramping, and overall symptom scores in lactose-intolerant individuals. Research has also demonstrated the strain's capacity to produce bacteriocins that inhibit Helicobacter, C. difficile, and multidrug-resistant Shigella. It supports bile salt metabolism through bile salt hydrolase activity, which may contribute to cholesterol modulation. As a normal inhabitant of both the gastrointestinal and genitourinary tracts, L. acidophilus supports digestive, immune, and vaginal health.
Lactobacillus paracasei — 750 million CFU
Lactobacillus paracasei (Lacticaseibacillus paracasei) is a versatile probiotic with evidence across digestive, immune, and respiratory health. It produces exopolysaccharides (EPS) that support gut barrier integrity by upregulating tight junction proteins (ZO-1, Claudin-1, Occludin) and promoting M1/M2 macrophage balance. Studies suggest particular relevance for allergic conditions: multiple RCTs have evaluated the LP-33 strain in allergic rhinitis, with a systematic review providing significant evidence of beneficial clinical and immunologic effects including improved quality of life. Research on heat-killed L. paracasei MCC1849 demonstrated it effectively induced IL-12 production and significantly reduced cold symptoms in clinical trial subjects. For common cold prevention, the combination of L. paracasei 8700:2 with L. plantarum HEAL9 reduced the incidence, severity, and duration of cold episodes across multiple clinical trials. It is recognized as GRAS by the FDA and holds QPS status from EFSA.
Probiotic Blend
Vitabase
Probiotic Blend
  • ✓ Free shipping over $75
  • ✓ 90-day easy returns
  • ✓ Ships within hours
Probiotic Blend
$10.90
Ideal Users

Who Can Benefit from This Acidophilus Probiotic Blend?

This acidophilus Probiotic Blend is designed for adults seeking comprehensive gastrointestinal support. It may be particularly relevant for individuals looking to restore beneficial bacteria to the body, promote an excellent digestive system in the small and large intestines, and support healthy immune function.

People who have recently taken antibiotics may find the formula helpful, as research suggests that probiotic strains like Lactobacillus rhamnosus and Bacillus coagulans may help maintain gut microbiota balance during and after antibiotic use. Those experiencing occasional digestive discomfort—including bloating, gas, or irregular bowel habits—may also benefit from the multi-strain approach, which combines spore-forming strains with traditional Lactobacillus and Bifidobacterium species for broad-spectrum support.

The inclusion of prebiotics (FOS and XOS) makes this blend especially well-suited for those who want to nourish the beneficial bacteria already present in their gut, not just supplement with new organisms. By providing the substrate that probiotics need to flourish, these prebiotics help enhance the overall effectiveness of the formula.

Usage

How to Take This Probiotic Blend

Take one capsule daily with breakfast. For additional intestinal support, take one or two capsules with each meal.

Each bottle provides 120 vegetable capsules. The product may be refrigerated to help maximize shelf-life and potency.

About the author

Written by Greg Howlett

GH

Greg Howlett

Founder

Greg has spent over a decade helping customers choose the right natural-health products. He personally vets every formula we carry and writes these guides to cut through the marketing noise with practical, experience-based advice.

FAQ

Frequently asked questions

What probiotic strains are in this acidophilus Probiotic Blend?

This formula contains six probiotic strains: Bacillus subtilis (DE111®), Bacillus coagulans, Bifidobacterium bifidum, Lactobacillus rhamnosus, Lactobacillus acidophilus, and Lactobacillus paracasei. It also includes two prebiotic fibers—FOS (fructooligosaccharides) at 150 mg and XOS (Xylooligosaccharides) at 50 mg—that serve as food for the probiotics.

How many CFU does each capsule provide?

Each capsule delivers 750 million CFUs at the time of manufacture across the six-strain Probiotic Blend.

What do the prebiotics FOS and XOS do in a probiotic formula?

FOS and XOS are prebiotic fibers that selectively feed beneficial gut bacteria—particularly Bifidobacterium and Lactobacillus species. They resist digestion in the upper GI tract and are fermented in the colon, where studies suggest they promote the production of short-chain fatty acids that support intestinal barrier integrity, bowel regularity, and immune function. Including them alongside probiotic strains helps the beneficial bacteria thrive and enhances the overall effectiveness of the formula.

Why does this blend include spore-forming strains like Bacillus subtilis and Bacillus coagulans?

Spore-forming strains produce a tough, protective endospore that allows them to survive the acidic stomach environment and bile salts in the small intestine with near-complete viability. Research suggests that Bacillus subtilis spores survive gastric transit at a rate of nearly 100% and germinate in the intestine as metabolically active cells. This complements the non-spore-forming Lactobacillus and Bifidobacterium strains, which may be more vulnerable to gastric conditions.

Is this acidophilus Probiotic Blend gluten free?

Yes, this product is gluten free. It is formulated with GMO-free ingredients and uses vegetable capsules for easy digestion.

Should this probiotic be refrigerated?

Refrigeration is optional but may help maximize shelf-life and potency. The spore-forming strains (Bacillus subtilis and Bacillus coagulans) are inherently shelf-stable, while refrigeration may help preserve the viability of the Lactobacillus and Bifidobacterium strains over time.

Talk to an expert

Talk to Dr. Shannyn Fowl

Not sure if this is right for you? Book a free, no-pressure consultation for personalized guidance on your health goals.

Book your free consult
Who we are

About Vitabase

A family-run reseller of premium supplements — free shipping, a 90-day guarantee, and real people who know the products.

Learn more about us